Mandeep Singh

Mandeep Singh practices at Jhu - Wilmer Eye Institute in Middle River, Maryland.

Mandeep Singh's NPI, 1851747752, was assigned on May 10, 2016. Mandeep Singh holds Maryland license D48422.

Mandeep Singh's primary practice is Jhu - Wilmer Eye Institute, at 6201 Greenleigh Ave, Middle River, MD 21220 in Baltimore County. The practice phone is (410) 614-5115.

Mandeep Singh's primary practice is Jhu - Wilmer Eye Institute in Middle River, Maryland. Mandeep Singh is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Mandeep Singh to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mandeep Singh practices. Vendor and product names are available with a free account.

Ophthalmology is Mandeep Singh's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Mandeep Singh is licensed in Maryland.

CMS data shows 1,734 Medicare services from Mandeep Singh across 14 procedure codes in 2024, for 326 Medicare patients. Medicare paid $311,046 for them. Every service was in an office.

CMS counts 326 Medicare patients who saw Mandeep Singh in 2024. The largest group is 75 to 84, with 129 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mandeep Singh's median patient age at 72, with 60% women.

In 2024, Mandeep Singh wrote 30 Medicare Part D claims for 12 patients. 80% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $159 in total drug cost. In 2022, CMS named 28 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Mandeep Singh for performance year 2024, reported as part of a group.

CMS Open Payments shows 47 general payments to Mandeep Singh from 4 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 92% of the total. Janssen Pharmaceuticals, Inc paid the most, $42,109.